معرفی
Yaoqiu Zhu is a chemist with a strong academic and industry background. He served as an Assistant Professor in the Department of Chemistry and Biochemistry at the University of Texas at El Paso (UTEP), affiliated with the Border Biomedical Research Center. He transitioned to southern California in 2023, continuing NIH-funded collaborative studies and industry-sponsored pharmaceutical research. His research focuses on organic synthesis, medicinal chemistry, and drug discovery, particularly addressing clinical challenges in antithrombotics, anticancer agents, and antiviral therapies.
Education
- B.S. in Chemistry (2001), Peking University
- Ph.D. in Chemistry (2006), Northwestern University (advisor: Prof. Richard B. Silverman)
Research Interests
Dr. Zhu’s work integrates organic synthesis with medicinal chemistry to solve clinical drug conundrums. Key areas include:
- Development of novel cardiovascular and antiviral medications
- Innovative synthesis of complex natural products (e.g., Pavidolide B)
- Enzymatic and H2S-based drug delivery systems
- Addressing pharmacology challenges in blockbuster drugs like Plavix (clopidogrel)
- Green chemistry approaches for sustainable drug production
Grants & Collaborations
- NIH R01 grants (e.g., $500k+ for membrane ion channel studies)
- Industry partnerships (e.g., AbbVie, Beckman Research Institute)
- Collaborations with institutions like Harvard Medical School, Baylor College of Medicine, and University of Cincinnati
Labs & Teams
The Zhu Lab emphasizes translational research, welcoming graduate students and fostering interdisciplinary projects. Recent moves to southern California expand access to West Coast biomedical networks.
